Healthcare Provider from South India Jumps Over 8% After Announcing New 500-Bed Hospital Project - FII’s Increase Stake

Krishna Institute of Medical Sciences share price rose more than 8 per cent after the company announced plans to establish a new 500-bed multi-speciality hospital in Amaravati, Andhra Pradesh.

In an exchange filing, the company said it has entered into a long-term lease agreement with the Andhra Pradesh Capital Region Development Authority (APCRDA) for 2 acres of land in Amaravati. The lease agreement is for a period of 60 years.

The proposed hospital will be developed as a state-of-the-art multi-speciality facility offering tertiary and quaternary healthcare services. The hospital is expected to provide advanced treatment across several key specialties, including cardiology, oncology, neurosciences, gastroenterology, orthopaedics, mother and child care, critical care, and organ transplantation.

The company said the project aims to address the growing demand for advanced healthcare infrastructure in Amaravati and nearby districts of Andhra Pradesh. The facility is also expected to reduce the need for patients to travel to metro cities for specialised medical treatment.

FII’s Increased Stake

Foreign Institutional Investors (FIIs) slightly increased their stake in the company during the March 2026 quarter. FII holding rose to 14.57 per cent in March 2026 from 14.33 per cent in December 2025.

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences (KIMS) is one of India’s leading healthcare providers, operating a network of multi-speciality hospitals across South and West India. The company offers a wide range of advanced medical services, including tertiary and quaternary care, across specialties such as cardiology, oncology, neurosciences and organ transplantation.

Krishna Institute of Medical Sciences Ltd Share Price Performance

Krishna Institute of Medical Sciences share price surged 8.40 per cent on May 11, 2026, rising Rs 60.25 to Rs 777.85 during the trading session, following the company’s announcement

During the Intraday session, the stock made a high of Rs 776.65 and a low of Rs 709.85

Disclaimer: The article is for informational purposes only and not investment advice.